References
- Moore HG. Importance of the circumferential resection margin. J Am Coll Surg. 2020;230(6):1018–1019. doi:https://doi.org/10.1016/j.jamcollsurg.2020.03.021.
- Pellino G, Gallo G, Pallante P, et al. Noninvasive biomarkers of colorectal cancer: role in diagnosis and personalised treatment perspectives. Gastroenterol Res Pract. 2018;2018:2397863. doi:https://doi.org/10.1155/2018/2397863.
- Lugli A, Zlobec I, Berger MD, Kirsch R, Nagtegaal ID. Tumour budding in solid cancers. Nat Rev Clin Oncol. 2021;18(2):101–115. doi:https://doi.org/10.1038/s41571-020-0422-y.
- Doll R. The Pierre Denoix Memorial Lecture: nature and nurture in the control of cancer. Eur J Cancer. 1999;35(1):16–23. doi:https://doi.org/10.1016/s0959-8049(98)00348-7.
- Gabriel WB, Dukes CE, Bussey HJR. Lymphatic spread in cancer of the rectum. Br J Surg. 2005;23(90):395–413. doi:https://doi.org/10.1002/bjs.1800239017.
- Nagtegaal ID, Tot T, Jayne DG, et al. Lymph nodes, tumor deposits, and TNM: are we getting better?J Clin Oncol. 2011;29(18):2487–2492. doi:https://doi.org/10.1200/JCO.2011.34.6429.
- Belt EJ, van Stijn MF, Bril H, et al. Lymph node negative colorectal cancers with isolated tumor deposits should be classified and treated as stage III. Ann Surg Oncol. 2010;17(12):3203–3211. doi:https://doi.org/10.1245/s10434-010-1152-7.
- Liu C, Tian M, Pei H, et al. Prognostic value of the N1c in stage III and IV colorectal cancer: a propensity score matching study based on the surveillance, epidemiology, and end results (SEER) database. J Investig Surg., in press, doi: https://doi.org/10.1080/08941939.2021.1925787.
- Zheng K, Zheng N, Xin C, et al. The prognostic significance of tumor deposit count for colorectal cancer patients after radical surgery. Gastroenterol Res Pract. 2020;2020:1–8. doi:https://doi.org/10.1155/2020/2052561.
- Peparini N. Beyond T, N and M: the impact of tumor deposits on the staging and treatment of colorectal and gastric carcinoma. Surg Oncol. 2018;27(2):129–137. doi:https://doi.org/10.1016/j.suronc.2018.02.007.